Other News To Note
• pSivida Corp., of Watertown, Mass., said Iluvien (fluocinolone acetonide intravitreal implant) was launched in Germany in chronic diabetic macular edema by licensee Alimera Sciences Inc., of Atlanta. Earlier this month, Alimera resubmitted the new drug application for Iluvien, which has a PDUFA date of Oct. 17.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter